UniProt ID | TAF7_HUMAN | |
---|---|---|
UniProt AC | Q15545 | |
Protein Name | Transcription initiation factor TFIID subunit 7 | |
Gene Name | TAF7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 349 | |
Subcellular Localization | Nucleus . | |
Protein Description | Functions as a component of the DNA-binding general transcription factor complex TFIID, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. Present in both of the previously described TFIID species which either lack or contain TAFII30 (TFIID alpha and TFIID beta respectively).. | |
Protein Sequence | MSKSKDDAPHELESQFILRLPPEYASTVRRAVQSGHVNLKDRLTIELHPDGRHGIVRVDRVPLASKLVDLPCVMESLKTIDKKTFYKTADICQMLVSTVDGDLYPPVEEPVASTDPKASKKKDKDKEKKFIWNHGITLPLKNVRKRRFRKTAKKKYIESPDVEKEVKRLLSTDAEAVSTRWEIIAEDETKEAENQGLDISSPGMSGHRQGHDSLEHDELREIFNDLSSSSEDEDETQHQDEEDINIIDTEEDLERQLQDKLNESDEQHQENEGTNQLVMGIQKQIDNMKGKLQETQDRAKRQEDLIMKVENLALKNRFQAVLDELKQKEDREKEQLSSLQEELESLLEK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSKSKDDAP ------CCCCCCCCC | 45.71 | 30108239 | |
3 | Acetylation | -----MSKSKDDAPH -----CCCCCCCCCC | 61.29 | 25953088 | |
4 | Phosphorylation | ----MSKSKDDAPHE ----CCCCCCCCCCC | 33.73 | 30108239 | |
5 | Methylation | ---MSKSKDDAPHEL ---CCCCCCCCCCCH | 64.46 | 16415881 | |
5 | Acetylation | ---MSKSKDDAPHEL ---CCCCCCCCCCCH | 64.46 | 25953088 | |
5 | Ubiquitination | ---MSKSKDDAPHEL ---CCCCCCCCCCCH | 64.46 | 29967540 | |
24 | Phosphorylation | ILRLPPEYASTVRRA HHHCCHHHHHHHHHH | 16.18 | 27642862 | |
34 | Phosphorylation | TVRRAVQSGHVNLKD HHHHHHHHCCCCCHH | 25.03 | 25159151 | |
40 | Ubiquitination | QSGHVNLKDRLTIEL HHCCCCCHHCEEEEE | 35.28 | 32015554 | |
66 | Ubiquitination | DRVPLASKLVDLPCV CCCCCCHHHCCCHHH | 47.09 | 32015554 | |
78 | Ubiquitination | PCVMESLKTIDKKTF HHHHHHHCCCCHHHH | 53.35 | 32015554 | |
129 | Sumoylation | KDKDKEKKFIWNHGI CCCHHCHHHHHCCCC | 43.08 | - | |
129 | Sumoylation | KDKDKEKKFIWNHGI CCCHHCHHHHHCCCC | 43.08 | - | |
141 | Ubiquitination | HGITLPLKNVRKRRF CCCCCCCCHHHHHHH | 52.00 | 23000965 | |
145 | Ubiquitination | LPLKNVRKRRFRKTA CCCCHHHHHHHHHHH | 43.58 | 23000965 | |
155 | Ubiquitination | FRKTAKKKYIESPDV HHHHHHHHHCCCCCH | 51.24 | 29967540 | |
156 | Phosphorylation | RKTAKKKYIESPDVE HHHHHHHHCCCCCHH | 20.85 | 21406692 | |
159 | Phosphorylation | AKKKYIESPDVEKEV HHHHHCCCCCHHHHH | 19.49 | 25159151 | |
171 | Phosphorylation | KEVKRLLSTDAEAVS HHHHHHHHCCHHHHH | 28.91 | 29255136 | |
172 | Phosphorylation | EVKRLLSTDAEAVST HHHHHHHCCHHHHHH | 38.92 | 30266825 | |
178 | Phosphorylation | STDAEAVSTRWEIIA HCCHHHHHHHEEEEE | 21.21 | 24670416 | |
179 | Phosphorylation | TDAEAVSTRWEIIAE CCHHHHHHHEEEEEE | 32.95 | 24670416 | |
200 | Phosphorylation | ENQGLDISSPGMSGH HHCCCCCCCCCCCCC | 30.10 | 29255136 | |
201 | Phosphorylation | NQGLDISSPGMSGHR HCCCCCCCCCCCCCC | 26.30 | 29255136 | |
205 | Phosphorylation | DISSPGMSGHRQGHD CCCCCCCCCCCCCCC | 37.04 | 30266825 | |
213 | Phosphorylation | GHRQGHDSLEHDELR CCCCCCCCCCHHHHH | 29.95 | 25159151 | |
227 | Phosphorylation | REIFNDLSSSSEDED HHHHHHHCCCCCCCH | 30.91 | 26552605 | |
228 | Phosphorylation | EIFNDLSSSSEDEDE HHHHHHCCCCCCCHH | 45.22 | 26552605 | |
229 | Phosphorylation | IFNDLSSSSEDEDET HHHHHCCCCCCCHHH | 34.08 | 26552605 | |
230 | Phosphorylation | FNDLSSSSEDEDETQ HHHHCCCCCCCHHHC | 51.52 | 26552605 | |
236 | Phosphorylation | SSEDEDETQHQDEED CCCCCHHHCCCCHHH | 43.61 | 26552605 | |
249 | Phosphorylation | EDINIIDTEEDLERQ HHCCEECCHHHHHHH | 30.76 | 21406692 | |
264 | Phosphorylation | LQDKLNESDEQHQEN HHHHCHHHHHHHHHC | 45.43 | 29255136 | |
274 | Phosphorylation | QHQENEGTNQLVMGI HHHHCCHHHHHHHHH | 17.39 | 29255136 | |
291 | Acetylation | QIDNMKGKLQETQDR HHHHHHHHHHHHHHH | 41.29 | 23749302 | |
326 | Ubiquitination | QAVLDELKQKEDREK HHHHHHHHHHHHHHH | 58.22 | 24816145 | |
337 | Phosphorylation | DREKEQLSSLQEELE HHHHHHHHHHHHHHH | 28.79 | 22199227 | |
338 | Phosphorylation | REKEQLSSLQEELES HHHHHHHHHHHHHHH | 42.54 | 22199227 | |
345 | Phosphorylation | SLQEELESLLEK--- HHHHHHHHHHHC--- | 51.37 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
264 | S | Phosphorylation | Kinase | TAF1 | P21675 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
264 | S | Phosphorylation |
| 18669648 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TAF1_HUMAN | TAF1 | physical | 11592977 | |
NEMO_HUMAN | IKBKG | physical | 20211142 | |
TRI22_HUMAN | TRIM22 | physical | 20211142 | |
ZSCA1_HUMAN | ZSCAN1 | physical | 20211142 | |
THA_HUMAN | THRA | physical | 10409738 | |
VDR_HUMAN | VDR | physical | 10409738 | |
CDK7_HUMAN | CDK7 | physical | 18391197 | |
CDK9_HUMAN | CDK9 | physical | 18391197 | |
CPSF1_HUMAN | CPSF1 | physical | 9311784 | |
TAF9_HUMAN | TAF9 | physical | 22939629 | |
TRRAP_HUMAN | TRRAP | physical | 22939629 | |
TAF13_HUMAN | TAF13 | physical | 29111974 | |
TAF11_HUMAN | TAF11 | physical | 29111974 | |
TAF1_HUMAN | TAF1 | physical | 29111974 | |
TAF2_HUMAN | TAF2 | physical | 29111974 | |
TAF3_HUMAN | TAF3 | physical | 29111974 | |
TAF4_HUMAN | TAF4 | physical | 29111974 | |
TAF4B_HUMAN | TAF4B | physical | 29111974 | |
TAF5_HUMAN | TAF5 | physical | 29111974 | |
TAF6_HUMAN | TAF6 | physical | 29111974 | |
TAF8_HUMAN | TAF8 | physical | 29111974 | |
TAF9_HUMAN | TAF9 | physical | 29111974 | |
TAF9B_HUMAN | TAF9B | physical | 29111974 | |
TAF10_HUMAN | TAF10 | physical | 29111974 | |
TAF12_HUMAN | TAF12 | physical | 29111974 | |
TBP_HUMAN | TBP | physical | 29111974 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171 AND SER-264, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171 AND SER-264, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201 AND SER-264, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-213; SER-227; SER-228;SER-229 AND SER-230, AND MASS SPECTROMETRY. |